CP-675,206 In Patients With Advanced Melanoma

Clinical trial NCT00086489 · COMPLETED

Trial details

NCT number: NCT00086489
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2003-08-01
Primary completion: 2007-05-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.